NCT02453620 2026-04-13Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast CancerNational Cancer Institute (NCI)Phase 1 Active not recruiting57 enrolled